Obesity Treatment with Botulinum Toxin-A Is Not Effective: a Systematic Review and Meta-Analysis

Obes Surg. 2017 Oct;27(10):2716-2723. doi: 10.1007/s11695-017-2857-5.

Abstract

The effectiveness of gastric injections of botulinum toxin-A (BTA) as primary treatment for obesity is not well known since results in literature are discrepant. Hence, we aimed to systematically review and meta-analyze the available data to assess the real effect of BTA therapy. We searched MEDLINE, Embase, Cochrane, SCOPUS, EBSCO, LILACS, and BVS. We considered eligible only randomized controlled trials enrolling obese patients comparing BTA versus saline injections. Our initial search identified 8811 records. Six studies fulfilled eligibility criteria. After critical appraisal, two articles were excluded and we meta-analyzed the remainder. The mean difference for absolute weight loss and BMI reduction were 0.12 [CI 95%, - 1.14, 1.38] and - 0.06 [95% CI, - 0.92, 0.81], respectively. Therefore, we concluded that treatment of obesity with BTA is not effective.

Keywords: Botulinum toxins; Endoscopy; Gastric emptying; Meta-analysis; Obesity; Systematic review.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Humans
  • Neuromuscular Agents / therapeutic use*
  • Obesity / drug therapy*
  • Obesity / epidemiology
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Treatment Failure
  • Weight Loss / drug effects

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A